Medicare Enrolled

Dr. Eric Rishe, MD

Hematology & Oncology · Pembroke Pines, FL
12309 PEMBROKE RD, Pembroke Pines, FL 33025
9175706945
Registered in NPPES since 2007
NPI: 1023133550 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rishe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rishe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rishe

Dr. Eric Rishe is a hematology & oncology specialist in Pembroke Pines, FL, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Rishe received a total of $62,158 from 61 pharmaceutical and/or device companies across 581 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rishe is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $62,158 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 111691 Clear January 31, 2028 —
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$62,158
Total received (2018-2024)
Avg $8,880/year across 7 years
Top 13% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
581
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,376
2023
$2,633
2022
$2,116
2021
$3,496
2020
$4,751
2019
$11,894
2018
$35,892

Payments by company (2024)

Janssen Biotech, Inc.
$346
PFIZER INC.
$336
ABBVIE INC.
$213
Celgene Corporation
$93
GlaxoSmithKline, LLC.
$72
E.R. Squibb & Sons, L.L.C.
$56
Regeneron Healthcare Solutions, Inc.
$53
Alexion Pharmaceuticals, Inc.
$28
AstraZeneca Pharmaceuticals LP
$25
Genmab U.S., Inc.
$25
Karyopharm Therapeutics Inc.
$22
Astellas Pharma US Inc
$21
Rigel Pharmaceuticals, Inc.
$21
Cumberland Pharmaceuticals, Inc.
$19
Lilly USA, LLC
$16
Menarini Silicon Biosystems, Inc.
$15
RECORDATI_RARE_DISEASES_INC.
$14
Top 3 companies account for 65.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amarin Pharma Inc.
$50,741
Janssen Biotech, Inc.
$1,439
E.R. Squibb & Sons, L.L.C.
$1,211
PFIZER INC.
$858
MACROGENICS, INC.
$819
Novartis Pharmaceuticals Corporation
$652
Celgene Corporation
$595
GENZYME CORPORATION
$551
AstraZeneca Pharmaceuticals LP
$541
Rigel Pharmaceuticals, Inc.
$507
Lilly USA, LLC
$370
Incyte Corporation
$353
Merck Sharp & Dohme LLC
$321
GlaxoSmithKline, LLC.
$276
Seagen Inc.
$254
ABBVIE INC.
$242
Merck Sharp & Dohme Corporation
$196
Eisai Inc.
$157
Myriad Genetic Laboratories, Inc.
$137
Genentech USA, Inc.
$128
Alexion Pharmaceuticals, Inc.
$127
Daiichi Sankyo Inc.
$120
JAZZ PHARMACEUTICALS INC.
$119
Karyopharm Therapeutics Inc.
$112
Ipsen Biopharmaceuticals, Inc
$89
Astellas Pharma US Inc
$86
Mirati Therapeutics, Inc.
$82
EMD Serono, Inc.
$81
Dova Pharmaceuticals
$58
Amgen Inc.
$54
Regeneron Healthcare Solutions, Inc.
$53
EISAI INC.
$49
Clovis Oncology, Inc.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$47
Genmab U.S., Inc.
$45
ARRAY BIOPHARMA INC
$42
Deciphera Pharmaceuticals Inc.
$41
Octapharma USA, Inc.
$39
Janssen Pharmaceuticals, Inc
$39
Adaptive Biotechnologies Corporation
$36
TAIHO ONCOLOGY, INC.
$36
Teva Pharmaceuticals USA, Inc.
$32
Boston Scientific Corporation
$30
Organon LLC
$29
AbbVie Inc.
$25
Mylan Institutional Inc.
$25
Global Blood Therapeutics, Inc.
$23
Sirtex Medical Inc
$21
Jazz Pharmaceuticals Inc.
$20
Gilead Sciences, Inc.
$19
Cumberland Pharmaceuticals, Inc.
$19
Agios Pharmaceuticals, Inc.
$19
Spectrum Pharmaceuticals Inc.
$19
Advanced Accelerator Applications
$19
Amneal Pharmaceuticals LLC
$18
Heron Therapeutics, Inc.
$17
Taiho Oncology, Inc.
$16
Menarini Silicon Biosystems, Inc.
$15
RECORDATI_RARE_DISEASES_INC.
$14
Blueprint Medicines Corporation
$14
Smith & Nephew, Inc.
$13
Top 3 companies account for 85.9% of all-time payments
Associated products mentioned in payments ›
AKEEGA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · BAVENCIO · BENDEKA · BLENREP · BOSULIF · CABLIVI · CALQUENCE · CHANTIX · CINVANTI · CYRAMZA · Cellsearch · DARZALEX · Doptelet · ELIQUIS · ELITEK · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Epkinly · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MARGENZA · MEKINIST · MYRISK · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SYLVANT · Santyl · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TUKYSA · Tavalisse · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · Vascepa · Venclexta · XALKORI · XARELTO · XPOVIO · Xtandi · ZEJULA · ZEPZELCA · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Pembroke Pines?
Compare hematology & oncology specialists in the Pembroke Pines area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
201
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
SOUTH FLORIDA STATE HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rishe is a hematology & oncology specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Rishe receive payments from pharmaceutical companies?
Yes. Dr. Rishe received a total of $62,158 from 61 companies across 581 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Rishe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Hematology & Oncology Specialists in Pembroke Pines
Browse hematology & oncology specialists in Pembroke Pines ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Amarin Pharma Inc. Payments to Doctors
See all physicians who received payments from Amarin Pharma Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →